Literature DB >> 8701752

Effects of Panax notoginseng saponins on posthypoxic cell damage of neurons in vitro.

K Y Jiang1, Z N Qian.   

Abstract

AIM: To study cerebral protective mechanism of Panax notoginseng saponins (PNS).
METHODS: Cultured neurons of chick embryo cerebral hemisphere were used as an in vitro system for investigating the effects of PNS. The hypoxic cell damage of neurons cultured were induced by NaCN. The levels of adenosine triphosphate (ATP) were determined with HPLC. PNS was added 30 min before, beginning or after hypoxia.
RESULTS: PNS 50 and 100 mg L-1 retarded the break down of ATP of cultured neurons after 2-h hypoxia for 11.3 +/- 1.5 (P < 0.05) and 12.8 +/- 2.2 mumol/g protein (P < 0.01), respectively and accelerated the restoration of ATP during 30-min reoxygenation for 21.0 +/- 2.0 (P < 0.05) and 22.7 +/- 2.6 mumol/g protein (P < 0.01), respectively. PNS also reduced the release of creatine kinase (CK) from 75 +/- 8 kU L-1/g protein to 52 +/- 6 (P < 0.05) and 41 +/- 3 kU L-1/mg protein (P < 0.01), respectively and promoted the restoration of ATP of neurons 20 h after hypoxia when administered in the beginning of hypoxia from 13.0 +/- 0.9 mumol/g protein to 18.1 +/- 1.4 and 20.5 +/- 2.1 mumol/g protein (P < 0.01), respectively. PNS still promoted the restoration of ATP from 13.0 +/- 0.9 nmol/mg protein to 14.9 +/- 1.0 and 18.3 +/- 0.7 nmol/mg protein (P < 0.01), respectively and reduced (PNS 100 mg L-1) the CK release of neurons 20 h after hypoxia even when added in the recovery.
CONCLUSION: The protection against hypoxic damage of PNS was related to improving energy metabolism, preserving the structural integrity of neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8701752

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  9 in total

Review 1.  Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.

Authors:  Youngmin Bu; Kyungjin Lee; Hyuk-Sang Jung; Sang-Kwan Moon
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

2.  Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng.

Authors:  Celine A Beamer; David M Shepherd
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-21       Impact factor: 4.147

3.  Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson's disease.

Authors:  Xinmu Zhang; Yingzi Wang; Cheng Ma; Yan Yan; Yang Yang; Xin Wang; Wolf-Dieter Rausch
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

4.  Saponin accumulation in the seedling root of Panax notoginseng.

Authors:  Dong Wang; Hongtao Zhu; Keke Chen; Min Xu; Yingjun Zhang; Chongren Yang
Journal:  Chin Med       Date:  2011-01-24       Impact factor: 5.455

5.  Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats.

Authors:  Ye Xiong; Ling Shen; Kristina J Liu; Patrick Tso; Yuqing Xiong; Guangji Wang; Stephen C Woods; Min Liu
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

6.  Protective Effect of Ginsenoside R0 on Anoxic and Oxidative Damage In vitro.

Authors:  Zhou Jiang; Yuhui Wang; Xiaoyun Zhang; Tao Peng; Yanqing Li; Yi Zhang
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

7.  Intervention Effects of Atorvastatin Combined with Panax notoginseng Saponins on Rats with Atherosclerosis Complicated with Hepatic Injury.

Authors:  Qing-Fang Jiang; Min-Yi Huang; Kang-Yuan Wu; Jie-Ling Weng; Rong-Gui Deng; Xin-Jie Xu; Jian-Pei Xu; Tao Jiang
Journal:  Pharmacogn Mag       Date:  2017-07-19       Impact factor: 1.085

8.  Anti-oxidative effects of the biennial flower of Panax notoginseng against H2O2-induced cytotoxicity in cultured PC12 cells.

Authors:  Roy Chi-Yan Choi; Zhiyong Jiang; Heidi Qun Xie; Anna Wing-Han Cheung; David Tai-Wai Lau; Qiang Fu; Tina Tingxia Dong; Jijun Chen; Zhengtao Wang; Karl Wah-Keung Tsim
Journal:  Chin Med       Date:  2010-10-28       Impact factor: 5.455

9.  Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo.

Authors:  Yu-Zhu Wang; Qing Xu; Wei Wu; Ying Liu; Ying Jiang; Qing-Qing Cai; Qian-Zhou Lv; Xiao-Yu Li
Journal:  Front Pharmacol       Date:  2018-04-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.